AVBP ArriVent BioPharma, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$28.27
· of 52w range
· above low
· to high
$17.0052w low
$35.8352w high
Market Cap (MRQ)
$1.37B
P/E
-6.5
EPS
$-4.32
your badges
52W Range
$17–$36
Analyst Rating
BUY
Price Target
$45
P/E
-6.5
ROE
-59.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
AVBP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$28.27
Market Cap (MRQ)
$1.37B
P/E
-6.5
EPS
$-4.32
ROE
-59.7%
52W Range
$17–$36
AVBP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-4.322023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | AVBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -6.5 | · | · | · | |
| P/B (MRQ) | 3.7 | · | 4.6 | Fair value | |
| Price / Cash Flow | -7.5 | · | · | · | |
| Price / Tangible Book | 3.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | AVBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -54.7% | · | -37.9% | Weak | |
| ROE | -59.7% | · | -43.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | AVBP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 14.2 | · | 11.1 | Strong liquidity | |
| Quick Ratio | 12.1 | · | 4.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-34.8%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-1.05 | $-1.01 | -4.3% |
| March 31, 2026 | May 13, 2026 | $-0.96 | $-0.91 | -5.2% |
| Dec. 31, 2025 | $-0.78 | $-0.86 | 9.8% | |
| Sept. 30, 2025 | $-0.83 | $-0.81 | -3.1% | |
| June 30, 2025 | $-0.90 | $-0.72 | -25.4% | |
| March 31, 2025 | $-1.90 | $-0.68 | -180.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $153M | $79M | $65M | |
| SG&A Expense | $24M | $15M | $10M | |
| Operating Expenses | $178M | $94M | $75M | |
| Operating Income | $-178M | $-94M | $-75M | |
| Net Income | $-166M | $-80M | $-69M | |
| EPS (Basic) | $-4.32 | $-2.56 | $-32.38 | |
| EPS (Diluted) | $-4.32 | $-2.56 | $-32.38 | |
| Shares (Basic) | 38,462,600 | 31,469,328 | 2,140,951 | |
| Shares (Diluted) | 38,462,600 | 31,469,328 | 2,140,951 | |
| EBITDA | $-181M | $-94M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $46M | $74M | $150M | |
| Short-term Investments | $267M | $145M | · | |
| Prepaid Expense | $20M | $8M | $10M | |
| Current Assets | $333M | $227M | $160M | |
| Other Non-current Assets | $190.0K | $126.0K | $107.0K | |
| Total Assets | $333M | $275M | $163M | |
| Accounts Payable | $6M | $4M | $5M | |
| Accrued Liabilities | $20M | $13M | $7M | |
| Current Liabilities | $26M | $17M | $12M | |
| Capital Leases | · | $14.0K | $177.0K | |
| Total Liabilities | $26M | $17M | $12M | |
| Common Stock | $4.0K | $3.0K | · | |
| Paid-in Capital | $712M | $496M | $5M | |
| Retained Earnings | $-405M | $-238M | $-158M | |
| AOCI | $14.0K | $-211.0K | · | |
| Stockholders' Equity | $307M | $258M | $-153M | |
| Liabilities + Equity | $333M | $275M | $163M | |
| Shares Outstanding | 42,452,251 | 33,706,765 | 2,745,480 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $-3M | · | · | |
| Stock-based Comp | $13M | $3M | $895.0K | |
| Other Non-cash | $-4M | · | · | |
| Operating Cash Flow | $-161M | $-70M | $-56M | |
| Investing Cash Flow | $-71M | $-192M | · | |
| Stock Issued | $203M | $186M | · | |
| Net Stock Activity | $203M | · | · | |
| Financing Cash Flow | $203M | $187M | $43M | |
| Net Change in Cash | $-29M | $-76M | $-13M | |
| Taxes Paid | $0 | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -54.7% | -36.8% | · | |
| ROE | -59.7% | -30.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.8 | 13.1 | · | |
| Quick Ratio | 12.1 | 12.7 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $7.24 | $7.64 | · | |
| Cash Flow / Share | $-4.18 | $-2.23 | · | |
| Cash / Share | $1.07 | $2.20 | · | |
| EPS (TTM) | $-4.32 | $-2.56 | $-32.38 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-166M | $-80M | $-69M | |
| Market Cap | $854M | $898M | · | |
| P/E | -4.7 | -10.4 | · | |
| P/B | 2.8 | 3.5 | · | |
| P / Tangible Book | 2.8 | 3.5 | · | |
| P / Cash Flow | -5.3 | -12.8 | · | |
| Earnings Yield | -21.5% | -9.6% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $42M | $38M | $32M | $32M | $28M | $61M | $20M | $20M | $22M | $17M | $20M | $14M | $20M | $10M | |
| SG&A Expense | $10M | $8M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $53M | $46M | $39M | $38M | $34M | $67M | $24M | $24M | $26M | $21M | $23M | $17M | $23M | $12M | |
| Operating Income | $-53M | $-46M | $-39M | $-38M | $-34M | $-67M | $-24M | $-24M | $-26M | $-21M | $-23M | $-17M | $-23M | $-12M | |
| Interest Income | · | · | · | · | · | · | · | $4M | $4M | $3M | · | $2M | $1M | · | |
| Net Income | $-50M | $-43M | $-36M | $-35M | $-31M | $-64M | $-21M | $-21M | $-22M | $-17M | $-21M | $-14M | $-22M | $-12M | |
| EPS (Basic) | $-1.05 | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | $-5.52 | $-10.79 | $-9.45 | |
| EPS (Diluted) | $-1.05 | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | $-5.52 | $-10.79 | $-9.45 | |
| Shares (Basic) | 47,606,857 | 45,067,658 | · | 41,912,905 | 35,006,114 | 33,898,870 | · | 33,581,810 | 33,502,347 | 25,046,531 | · | 2,607,192 | 1,999,705 | 1,287,574 | |
| Shares (Diluted) | 47,606,857 | 45,067,658 | · | 41,912,905 | 35,006,114 | 33,898,870 | · | 33,581,810 | 33,502,347 | 25,046,531 | · | 2,607,192 | 1,999,705 | 1,287,574 | |
| EBITDA | $-53M | $-47M | · | $-38M | $-34M | $-67M | · | $-24M | $-26M | $-21M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $62M | $46M | $113M | $113M | $50M | $74M | $283M | $299M | $317M | $150M | · | · | · | |
| Short-term Investments | $218M | $264M | $267M | $188M | $123M | $126M | $145M | · | · | · | · | · | · | · | |
| Prepaid Expense | $21M | $22M | $20M | $21M | $14M | $10M | $8M | $10M | $10M | $10M | $10M | · | · | · | |
| Current Assets | $394M | $349M | $333M | $321M | $250M | $186M | $227M | $292M | $309M | $327M | $160M | · | · | · | |
| Other Non-current Assets | $134.0K | $156.0K | $190.0K | $180.0K | $479.0K | $176.0K | $126.0K | $126.0K | $125.0K | $108.0K | $107.0K | · | · | · | |
| Total Assets | $395M | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | · | · | · | |
| Accounts Payable | $2M | $9M | $6M | $6M | $4M | $4M | $4M | $5M | $4M | $4M | $5M | · | · | · | |
| Accrued Liabilities | $25M | $16M | $20M | $16M | $15M | $8M | $13M | $10M | $8M | $6M | $7M | · | · | · | |
| Current Liabilities | $28M | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | · | · | · | |
| Capital Leases | $33.0K | $320.0K | · | · | · | · | $14.0K | $56.0K | $98.0K | $138.0K | $177.0K | · | · | · | |
| Total Liabilities | $28M | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | · | |
| Paid-in Capital | $865M | $772M | $712M | $674M | $584M | $505M | $496M | $495M | $494M | $493M | $5M | · | · | · | |
| Retained Earnings | $-498M | $-448M | $-405M | $-369M | $-334M | $-303M | $-238M | $-218M | $-197M | $-175M | $-158M | · | · | · | |
| AOCI | $-267.0K | $-270.0K | $14.0K | $206.0K | $-18.0K | $-17.0K | $-211.0K | · | · | · | · | · | · | · | |
| Stockholders' Equity | $367M | $324M | $307M | $305M | $250M | $203M | $258M | $277M | $297M | $318M | $-153M | · | · | · | |
| Liabilities + Equity | $395M | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | · | · | · | |
| Shares Outstanding | 48,319,591 | 45,308,941 | 42,452,251 | 40,852,312 | 37,490,439 | 34,040,996 | 33,706,765 | 33,694,355 | 33,509,090 | 33,493,750 | 2,745,480 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-515.0K | $-559.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $7M | $5M | $3M | $4M | $3M | $2M | $952.0K | $866.0K | $765.0K | $625.0K | $319.0K | $217.0K | $193.0K | $166.0K | |
| Other Non-cash | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-40M | $-42M | $-31M | $-36M | $-26M | $-68M | $-16M | $-16M | $-19M | $-19M | $-15M | $-15M | $-9M | $-17M | |
| Investing Cash Flow | $46M | $4M | $-71M | $-51M | $14M | $37M | · | · | · | · | · | $0 | · | · | |
| Stock Issued | $85M | $55M | $35M | $86M | $75M | $7M | $0 | · | · | $186M | · | · | · | · | |
| Net Stock Activity | · | $55M | · | · | · | · | · | · | · | $186M | · | · | · | · | |
| Financing Cash Flow | $86M | $55M | $35M | $86M | $75M | $7M | $55.0K | $531.0K | $363.0K | $186M | $-1M | $-1M | $-20.0K | $45M | |
| Net Change in Cash | $93M | $17M | $-67M | $-93.0K | $63M | $-24M | $-209M | $-16M | $-19M | $167M | $9M | $-16M | $-34M | $28M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -15.3% | · | -11.3% | -10.9% | -23.7% | · | -14.1% | -14.2% | -10.6% | · | · | · | · | |
| ROE | -16.2% | -16.5% | · | -12.0% | -11.5% | -24.8% | · | -14.8% | -14.8% | -11.0% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 14.0 | · | 14.9 | 12.7 | 14.3 | · | 19.3 | 25.5 | 32.8 | · | · | · | · | |
| Quick Ratio | 13.4 | 13.1 | · | 13.9 | 12.0 | 13.6 | · | 18.7 | 24.7 | 31.8 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.59 | $7.15 | · | $7.47 | $6.66 | $5.95 | · | $8.24 | $8.85 | $9.49 | · | · | · | · | |
| Cash Flow / Share | · | $-0.93 | · | · | · | $-2.01 | · | · | · | $-0.74 | · | · | · | · | |
| Cash / Share | $3.20 | $1.37 | · | $2.76 | $3.01 | $1.46 | · | $8.39 | $8.91 | $9.48 | · | · | · | · | |
| EPS (TTM) | $-3.53 | $-3.38 | · | $-4.23 | $-4.01 | $-3.76 | · | $-8.58 | $-13.49 | $-23.63 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-164M | $-145M | · | $-151M | $-137M | $-127M | · | $-81M | $-75M | $-75M | · | · | · | · | |
| Market Cap | $1.68B | $1.05B | · | $754M | $816M | $629M | · | $792M | $622M | $598M | · | · | · | · | |
| P/E | -9.8 | -6.8 | · | -4.4 | -5.4 | -4.9 | · | -2.7 | -1.4 | -0.8 | · | · | · | · | |
| P/B | 4.6 | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | · | · | · | |
| P / Tangible Book | 4.6 | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | · | · | · | |
| P / Cash Flow | · | -25.0 | · | · | · | -9.3 | · | · | · | -32.1 | · | · | · | · | |
| Earnings Yield | -10.2% | -14.6% | · | -22.9% | -18.4% | -20.3% | · | -36.5% | -72.7% | -132.3% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income | $-166M | $-80M | $-69M |
| Diluted EPS | $-4.32 | $-2.56 | $-32.38 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Current Ratio | 12.8 | 13.1 | · |
| Quick Ratio | 12.1 | 12.7 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 167 filers · $1.7B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
167
Value held
$1.7B
New positions
33
Exited positions
14
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 33 (-10 vs prior Q) | 14 (-1 vs prior Q) | 73 (+18 vs prior Q) | 33 (+5 vs prior Q) | +4.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $156,869,547 | 4,515,531 | 9.43% | Shares |
| INFINITUM ASSET MANAGEMENT, LLC | $154,189,460 | 4,438,384 | 9.27% | Shares |
| HHLR ADVISORS, LTD. | $136,497,525 | 3,929,117 | 8.21% | Shares |
| BlackRock, Inc. | $112,918,757 | 3,250,396 | 6.79% | Shares |
| ORBIMED ADVISORS LLC | $105,169,375 | 3,027,328 | 6.32% | Shares |
| FMR LLC | $96,541,033 | 2,778,959 | 5.81% | Shares |
| Octagon Capital Advisors LP | $68,474,416 | 1,971,054 | 4.12% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $61,659,088 | 1,774,873 | 3.71% | Shares |
| Sofinnova Investments, Inc. | $58,945,164 | 1,696,752 | 3.54% | Shares |
| STATE STREET CORP | $58,814,334 | 1,692,986 | 3.54% | Shares |
| Vivo Capital, LLC | $58,436,050 | 1,682,097 | 3.51% | Shares |
| NOVO HOLDINGS A/S | $52,110,000 | 1,500,000 | 3.13% | Shares |
| General Catalyst Group Management, LLC | $51,928,866 | 1,494,786 | 3.12% | Shares |
| VANGUARD GROUP INC | $37,609,632 | 1,869,266 | 2.26% | Shares |
| Logos Global Management LP | $34,740,000 | 1,000,000 | 2.09% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $33,795,640 | 972,626 | 2.03% | Shares |
| D. E. Shaw & Co., Inc. | $30,293,662 | 872,011 | 1.82% | Shares |
| GOLDMAN SACHS GROUP INC | $29,658,337 | 853,723 | 1.78% | Shares |
| HSG Holding Ltd | $23,043,320 | 663,308 | 1.39% | Shares |
| Point72 Asset Management, L.P. | $19,690,493 | 566,796 | 1.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $17,658,342 | 508,300 | 1.06% | Call option |
| MILLENNIUM MANAGEMENT LLC | $15,239,187 | 438,664 | 0.92% | Shares |
| UBS Group AG | $15,236,756 | 438,594 | 0.92% | Shares |
| Balyasny Asset Management L.P. | $13,737,829 | 395,447 | 0.83% | Shares |
| AMERIPRISE FINANCIAL INC | $13,256,401 | 381,589 | 0.80% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11,649,017 | 335,320 | 0.70% | Shares |
| NORTHERN TRUST CORP | $11,559,840 | 332,753 | 0.70% | Shares |
| Foresite Capital Management VI LLC | $10,468,586 | 301,341 | 0.63% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10,221,342 | 294,224 | 0.61% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $9,007,735 | 259,290 | 0.54% | Shares |
| Seven Fleet Capital Management LP | $8,567,092 | 246,606 | 0.52% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $7,597,430 | 218,694 | 0.46% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $7,347,651 | 211,509 | 0.44% | Shares |
| MORGAN STANLEY | $6,597,474 | 189,910 | 0.40% | Shares |
| Squadron Capital Management LLC | $6,357,420 | 183,000 | 0.38% | Call option |
| BANK OF AMERICA CORP /DE/ | $6,074,845 | 174,866 | 0.37% | Shares |
| CITADEL ADVISORS LLC | $5,445,217 | 156,742 | 0.33% | Shares |
| NOMURA HOLDINGS INC | $5,371,395 | 154,617 | 0.32% | Shares |
| Woodline Partners LP | $5,128,979 | 147,639 | 0.31% | Shares |
| JANE STREET GROUP, LLC | $4,811,490 | 138,500 | 0.29% | Call option |
| Affinity Asset Advisors, LLC | $4,342,500 | 125,000 | 0.26% | Shares |
| E Fund Management Co., Ltd. | $3,798,055 | 109,328 | 0.23% | Shares |
| Nuveen, LLC | $3,746,745 | 107,851 | 0.23% | Shares |
| Bank of New York Mellon Corp | $3,610,563 | 103,931 | 0.22% | Shares |
| KVP Capital Advisors, LP | $3,543,480 | 102,000 | 0.21% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $3,503,702 | 100,855 | 0.21% | Shares |
| Burkehill Global Management, LP | $3,474,000 | 100,000 | 0.21% | Shares |
| CITADEL ADVISORS LLC | $2,834,784 | 81,600 | 0.17% | Call option |
| SECTORAL ASSET MANAGEMENT INC | $2,745,954 | 79,043 | 0.17% | Shares |
| Trexquant Investment LP | $2,496,416 | 71,860 | 0.15% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC, OrbiMed Asia GP IV, L.P., OrbiMed Advisors IV Limited ×2 filings | Aug. 13, 2025 | 7.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 5 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zhengbin Yao | President and CEO | Feb. 2, 2026 A | · | 0 | 0 | $0 |
| Winston Kung | Chief Financial Officer | Feb. 2, 2026 A | · | 0 | 0 | $0 |
| Stuart Lutzker | President of R&D | Feb. 2, 2026 A | · | 0 | 0 | $0 |
| Robin Lachapelle | Chief Operating Officer | Feb. 2, 2026 A | 135,736 | 0 | 0 | $0 |
| James Paul Kastenmayer | General Counsel | Feb. 2, 2026 A | · | 0 | 0 | $0 |
| Merdad Parsey | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Chris Nolet | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| John Hohneker | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Kristine Peterson | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| GORDON CARL L | Director | Jan. 30, 2024 C | 1,513,664 | 0 | 0 | $0 |
| Dr. James I. Healy | Director | Jan. 30, 2024 C | 1,696,752 | 0 | 0 | $0 |
| Bahija Jallal | Director | Jan. 25, 2024 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 29 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.65% | 10,177 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.26% | 128,960 SH | Sept. 11, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.18% | 29,803 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.10% | 3,477 SH | Oct. 1, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 40,649 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.07% | 354,751 SH | Sept. 11, 2026 | Daily |
| IBB · iShares Trust | 0.07% | 248,617 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.05% | 407 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 218,131 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.04% | 18,120 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.04% | 966,808 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 15,010 SH | Oct. 1, 2026 | Daily |
| ISCG · iShares Trust | 0.01% | 4,464 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 55,858 NS | July 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 11,553 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 396,954 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 73,260 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 1,255 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 49,419 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 7,705 SH | Sept. 10, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 1,208 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 2,586 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 4,731 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 1,725 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,338,764 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,280 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 1,457 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 4,084 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 5,229 SH | Aug. 19, 2026 | Daily |
AVBP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$45.00
+59.2%
7 38.9%
Strong Buy
10 55.6%
Buy
1 5.6%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-30Mean target $44.70 +58.1%
← Below all targets
Current price $28.27
Low$40.00
Mean$44.70
High$50.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| COAG | · | · | · | · | · | · |
| KLRA | · | · | · | · | · | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026